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ABSTRACT 
Purpose: Caffeine enhances exercise performance but its mechanisms of action remain 
unclear. This study investigated its effects on neuromuscular function in a non-fatigued 
state and during fatiguing exercise.  
Methods: Eighteen males participated in this randomised, double-blind, placebo-
controlled crossover trial. Baseline measures included plantarflexion force, drop jump, 
squat jump, voluntary activation of triceps surae muscle, soleus muscle contractile 
properties, M-wave, alpha-motoneuron excitability (H-reflex), corticospinal excitability, 
short-interval intracortical inhibition (SICI), intracortical facilitation (ICF), silent period 
evoked by transcranial magnetic stimulation (SP) and plasma potassium and caffeine 
concentration. Immediately after baseline testing, participants ingested caffeine (6 
mg·kg-1) or placebo. After a 1-h rest, baseline measures were repeated, followed by a 
fatiguing stretch-shortening cycle exercise (sets of 40 bilateral rebound jumps on a 
sledge apparatus) until task failure. Neuromuscular testing was carried out throughout 
and after the fatigue protocol.  
Results: Caffeine enhanced drop jump height (4.2%) and decreased SP (12.6%) in a 
non-fatigued state. A caffeine-related decrease in SP and SICI prior to the fatiguing 
activity was associated with an increased time to task failure. The participants who 
benefited from an improved performance on the caffeine day, reported a significantly 
lower sense of effort during exercise and had an accelerated post-exercise recovery of 
M-wave amplitude.   
Conclusion: Caffeine modulates inhibitory mechanisms of the central nervous system, 
recovery of M-wave amplitude and perception of effort.  This study lays the groundwork 
for future examinations of differences of caffeine-induced neuromuscular changes 




Keywords: central fatigue, peripheral fatigue, transcranial magnetic stimulation, rate of 
perceived exertion, soleus  
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NEW FINDINGS 
 What is the central question of the study? 
What are the effects of caffeine on neuromuscular function in a non-fatigued 
state and during fatiguing exercise? 
 
 What is the main finding and its importance? 
In a non-fatigued state caffeine decreased the duration of the silent period 
evoked by TMS. A caffeine-induced reduction of inhibitory mechanisms in the 
central nervous system prior to exercise was associated with an increased 
performance. Individuals who benefit from caffeine ingestion may experience 
lower perception of effort during exercise and an accelerated recovery of M-
wave amplitude post fatigue. This study elucidates caffeine’s mechanisms of 
action and demonstrates that inter-individual variability of its effects on 




Central Nervous System                                                                                         CNS  
Intracortical facilitation                                 ICF 
Maximal isometric voluntary contraction                               MVC 
Maximal M-wave                                             Mmax 
Maximum instantaneous ascending rate of force development                RFDmax 
Motor evoked potential                    MEP 
Motor threshold                                                   MT 
Potassium                      K+ 
Potentiated twitch                     PTw 
Rate of force development                    RFD 
Rate of perceived exertion                    RPE 
Short-interval intracortical inhibition                  SICI 
Soleus muscle                     SOL 
Stretch-shortening cycle                                 SSC 
Superimposed twitch                    SIT 
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TMS-evoked silent period                                 SP 
Transcranial magnetic stimulation                                TMS 





Caffeine is the most widely consumed drug worldwide. Several studies and a number of 
reviews have documented the ergogenic effects of caffeine for aerobic endurance, 
muscle strength, muscle endurance, anaerobic power, jumping and short-term high 
intensity exercise performance (Burke, 2008; Davis & Green, 2009; Ganio, Klau, Casa, 
Amstrong, & Maresh, 2009; Terry E. Graham, 2001; Grgic et al., 2019; Southward, 
Rutherfurd-Markwick, & Ali, 2018). The current leading hypothesis for its mechanism of 
action is the enhancement of neural drive due to the reversal of inhibitory effects of 
adenosine, by blocking its receptors in the central nervous system (CNS). This blockage 
enhances dopaminergic transmission, which is associated with increased arousal and 
motivation, as well as an increase of serotonin release presynaptically and serotonergic 
input postsynaptically (Fredholm, Bättig, Holmén, Nehlig, & Zvartau, 1999). 
Furthermore, caffeine also seems to reduce sense of effort during exercise (Doherty and 
Smith 2005), likely through a modulation of afferent feedback from the working 
muscles, corollary discharges associated with the central motor command, or both 
(Pageaux, 2016).  
 
Effects of caffeine on the muscle itself are unlikely, since a number of studies were 
unable to demonstrate a significant effect of the drug on electrically-evoked contractile 
properties (Black, Waddell, & Gonglach, 2015; Del Coso, Estevez, & Mora-Rodriguez, 
2008; Eaton et al., 2016; Hespel, ‘t Eijnde, & Van Leemputte, 2002; Kalmar & Cafarelli, 
2006; Kalmar, Del Balso, & Cafarelli, 2006; Kalmar & Cafarelli, 1999; Kalmar & Cafarelli, 
2004; Neyroud et al., 2019; Plaskett & Cafarelli, 2001; Smirmaul, de Moraes, Angius, & 
Marcora, 2016). However, to date five studies have shown a caffeine-induced effect on 
contractile properties (Bazzucchi, Felici, Montini, Figura, & Sacchetti, 2011; Bowtell et 
al., 2018; Cureton et al., 2007; Meyers & Cafarelli, 2005; Tarnopolsky & Cupido, 2000), 
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so this hypothesis should not be dismissed. The idea of caffeine acting on the CNS 
through adenosine receptor antagonism is very attractive, but further research is 
needed to clarify the exact sites of action. 
 
Some research has shown a caffeine-induced attenuation of plasma potassium (K+) 
levels (Lindinger, Graham, & Spriet, 1993) and attenuated muscle interstitial K+ levels 
(Mohr, Nielsen, & Bangsbo, 2011), which could be translated into a beneficial effect at 
the neuromuscular junction. In fact, a caffeine-induced attenuation of neuromuscular 
transmission failure after fatigue, assessed by the maximal M-wave (Mmax), has been 
demonstrated (Bowtell et al., 2018).  
 
Effects of caffeine on the excitability of spinal motoneurones are likely but far from 
unequivocal: some authors have shown a positive effect in a non-fatigued state (Kalmar 
& Cafarelli, 1999; Walton, Kalmar, & Cafarelli, 2003; Walton, Kalmar, & Cafarelli, 2002) 
and during fatigue (Kalmar et al., 2006), whilst others did not observe a significant 
effect in a non-fatigued state (Behrens, Mau-Moeller, Heise, et al., 2015; Behrens, Mau-
Moeller, Weippert, et al., 2015; Kalmar et al., 2006). Some studies have attributed the 
ergogenic effects of caffeine to a decreased inhibition at the cortical or spinal level 
(Cerqueira, de Mendonça, Minez, Dias, & de Carvalho, 2006; de Carvalho, Marcelino, & 
de Mendonça, 2010), and an increased corticospinal excitability (Kalmar & Cafarelli, 
2006; Kalmar & Cafarelli, 2004), both of which may contribute to enhancing descending 
neural drive. However, some other studies have also been unable to observe an effect of 
caffeine on inhibitory or excitatory mechanisms at the cortical or spinal level (de 
Carvalho et al., 2010; Orth, Amann, Ratnaraj, Patsalos, & Rothwell, 2005).  
 
To date, only a handful of studies have concurrently investigated the effects of caffeine 
on neuromuscular function in a non-fatigued state, during fatigue and recovery. It is also 
important to take into consideration that some of the aforementioned discrepant results 
could be partly related to differences in the research designs that could modulate the 
influence of caffeine on neuromuscular function, such as the nature of the exercise task, 
muscle of interest, dose of caffeine (Sabol, Grgic, & Mikulic, 2019) and time of day 
(Mora-Rodríguez et al., 2015). Another possible contributor is the known large inter-
individual variability regarding the ergogenic effects of caffeine on exercise 
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performance (Doherty, Smith, Davison, & Hughes, 2002; Graham & Spriet, 1991; Green, 
Olenick, Eastep, & Winchester, 2017; Guest, Corey, Vescovi, & El-Sohemy, 2018; 
Roelands et al., 2011; Skinner, Jenkins, Coombes, Taaffe, & Leveritt, 2009; Wiles, 
Coleman, Tegerdine, & Swaine, 2006). A variety of factors potentially drive this inter-
individual variability such as sex and menstrual cycle stage (Lane, Steege, Rupp, & Kuhn, 
1992), training status (Collomp, Ahmaidi, Chatard, Audran, & Prefaut, 1992), habitual 
caffeine use (Lara, Ruiz-Moreno, Salinero, & Coso, 2019) and genetic variations that 
modify caffeine metabolism (Guest et al., 2018; Koonrungsesomboon, Khatsri, 
Wongchompoo, & Teekachunhatean, 2018). Presumably, all these factors contribute to 
an increased likelihood of encountering a masking effect in caffeine “responders”, which 
may not be revealed in the averaged data. Thus, as the degree of responsiveness of some 
individuals often contrasts to the average findings reported, it is necessary to take this 
inter-individual variability into consideration in order to further understand the 
magnitude of the caffeine-induced effects on different levels of the neuromuscular 
system. It is not yet known whether a differential modulation of caffeine on 
neuromuscular function is observed between those individuals who benefit from 
caffeine ingestion and those who do not. 
 
The aim of the present study was to investigate the underlying neuromuscular 
mechanisms that may be responsible for any caffeine-induced ergogenic effects in a 
non-fatigued state and during a fatiguing stretch-shortening cycle exercise (SSC) and 
recovery. It was hypothesised that 1) caffeine would result in an improvement in 
exercise performance in a non-fatigued state and in an increased resistance to fatigue 
during a fatiguing SSC exercise; and 2) that caffeine would not modulate contractile 
properties of the muscle, but would up-regulate excitatory mechanisms and down-





Participants were fully informed of any risks and discomforts associated with the 
procedures before giving their informed written consent to participate. The procedures 
were approved by the Ethics Committee of the University of Jyväskylä, and performed 
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according to the 1964 Helsinki Declaration and its later amendments, except 
registration in a database. 
 
Participants 
Eighteen healthy males (age: 26.6 ± 3.1 years; body mass: 75.3 ± 7.4 kg; height: 179.3 ± 
5.2 cm), who engage in recreational physical exercise, volunteered to participate in this 
study. The participants were non-smokers and were not overweight or obese, as 
cigarette smoking and adiposity may enhance the rate of caffeine degradation 
(Kamimori, Somani, Knowlton, & Perkins, 1987; Parsons & Neims, 1978). Participants 
had an average daily consumption of caffeine of 184 ± 157 mg (6 light consumers: 21 ± 
26mg; 12 regular consumers: 266 ± 125 mg), assessed by a 7-day questionnaire on 
intake of food and beverages containing caffeine.  
 
Procedures 
The participants visited the laboratory on 3 different occasions. The first visit was a 
familiarisation session where they were introduced to the electrophysiological 
techniques and the sledge apparatus, and the stimulation sites were marked for the 
upcoming sessions. In this session, the maximal jumping height was also determined in 
the sledge apparatus, by dropping the participants from progressively increasing 
heights (Horita, Komi, Nicol, & Kyröläinen, 1996). The sledge was inclined at 23º for all 
testing with the exception of one participant, where it was necessary to incline the 
sledge apparatus to 27º to allow maximal rebounding. The drop-jumps were preceded 
by a 5-min warm-up on a cycle ergometer at an intensity of 60 to 70% of individual 
predicted maximal heart rate, and 10 submaximal jumps in the sledge with increasing 
effort. Participants visited the laboratory for two subsequent experimental days - a 
placebo and a caffeine condition session, in a randomised order. Participants were 
asked to abstain from consuming caffeine-containing foods and beverages, alcohol 
consumption and physical exercise within 72 h of the experimental sessions. Each 
experimental session began with a precapsule test which was followed by the oral 
administration (double-blind) of a capsule containing either caffeine (6 mg•kg-1) or 
placebo (maltodextrin). An identical postcapsule protocol took place 60 min after the 
ingestion of the capsule. The postcapsule test was followed by the fatigue protocol and a 
15-min recovery period. The overall design of the experimental sessions is presented 
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schematically in Figure 1. The sessions took place 14 days apart. The participants were 
asked to wear the same shoes in the 3 visits. 
 
[INSERT FIGURE 1 HERE] 
 
Pre and postcapsule measurements 
The precapsule test began with a series of stimuli applied to the tibial nerve to evoke H-
reflex and M-wave recruitment curves in the soleus muscle (SOL). Transcranial 
magnetic stimulation (TMS) was then used to elicit evoked responses in SOL. The motor 
threshold (MT) was assessed, and, in a randomised order which was constant for each 
participant throughout the study, corticospinal excitability through unconditioned 
motor evoked potentials (MEP), short-interval intracortical inhibition (SICI) and 
intracortical facilitation (ICF) were assessed. Participants then performed a warm-up 
identical to the one performed in the familiarisation session, followed by the last part of 
the neuromuscular testing which included maximal isometric voluntary contractions 
(MVC) of the plantarflexors, single-pulse TMS during three voluntary contractions at 
50% of MVC to assess the TMS-evoked silent period (SP), and assessment of maximal 
squat jump and drop jump heights. A rest period of 2 min and 30 s was given between 
the MVC trials, and at least three attempts were completed. Subsequent trials were 
performed if the participant reached a force value more than 10% higher than his 
previous best attempt. Visual feedback of the force trace was continuously provided on 
a screen in front of the participant and the participants were instructed to contract as 
hard and as fast as possible. Standardised verbal encouragement was provided by the 
same investigator in all trials. During the MVC trials, a supramaximal single pulse 
stimulation was applied to the tibial nerve before MVC to assess M-max, and a 
supramaximal double pulse stimulation was applied during and two seconds after each 
attempted MVC to quantify voluntary activation (VA) of the triceps surae muscle 
through the interpolated twitch technique (Merton, 1954). The amplitude of the twitch 
after MVC was also used as an estimate of contractile properties. A minimum of three 
trials were performed for squat and drop jumps with 1-min rest between trials. 
Immediately after each squat jump, the force curve was inspected to identify any 
countermovement jump that would invalidate the jump. To perform the drop jumps, 
participants were dropped from their optimal height, assessed during the 
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familiarisation session. They were instructed to keep a knee angle of approximately 90º 
on landing, to keep their heels off of the force plate and to be as explosive as possible. 
These criteria were visually inspected by a research assistant. MVC, squat and drop 
jump trials were performed in a randomised order which was constant for each 
participant throughout the study, with SP being assessed immediately after MVCs.  
 
Fatigue protocol  
Participants performed a fatiguing SSC exercise on a sledge apparatus by repeating 
series of 40 submaximal bilateral jumps, with inter-series periods of 3 min where 
neuromuscular function was assessed. During the fatiguing sets, participants were 
asked to reach a rebound height of 70% of the best drop jump height that was reached 
either in the familiarisation session or during the precapsule measurements of the first 
session. One research assistant gave feedback to the participant after every jump 
regarding the rebound height, with the oral commands “GOOD”, “HIGHER” and “NOT SO 
HIGH”. Another research assistant gave feedback to ensure that the participant satisfied 
the jump criteria stated above. The exercise was stopped when the participant could not 
reach the submaximal rebound height 10 times in a row. During the inter-series 
periods, the following measures were performed: rate of perceived exertion (RPE), a 
train of 10 TMS single pulses, one plantarflexion MVC attempt performed with 
peripheral electrical stimuli, and TMS during three voluntary contractions at 50% of 
MVC to assess SP. Recovery measures were performed at 0, 5, 10 and 15 min from task 
failure. Recovery measures included the protocol applied during the inter-series periods 
of the fatigue protocol, followed by evoked H-reflexes with concomitant M-waves with a 
size equivalent to a pre-determined percentage of Mmax.  
 
RPE 
RPE was reported using a 6-20 Borg scale and the participants received an exercise-
specific description of how to rate perception of effort: “How hard is it for you to drive 
your legs and how heavy is your breathing?”. To provide a point of reference, exercise-
anchoring was performed and the participants were told that maximal exertion 
corresponds to the effort they experienced at exhaustion during an incremental test 
(Pageaux, 2016). 
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Position in the sledge for electrical stimulation, TMS and for MVCs  
Participants assumed a seated position in the sledge apparatus with the forefoot on a 
built-in force plate and the knees in full extension. This ensured a small activation of the 
plantarflexors with the ankles in a neutral position. The hips were at 50o of flexion (0o = 
extended neutral position). The sledge was locked in an unmovable position.  
  
Electrical Stimulation  
Electrical stimuli were given using a constant current stimulator (Model DS7AH, 
Digitimer Ltd., Welwyn Garden City, UK); a circular cathode with a surface area of 0.77 
cm2 (Unilect 4535M, Ag/AgCl, Unomedical Ltd., Redditch, UK) was placed over the tibial 
nerve on the popliteal fossa, and an oval shaped anode (5.08 x 10.16 cm) positioned 
superior to the patella (V-trodes, Mettler Electronics corp., Anaheim, USA). Square 
pulses with 1-ms pulse duration were applied to evoke M-waves and H-reflexes in SOL. 
The H and M-wave recruitment curves were generated with a series of single-pulses 
with interstimulus intervals that randomly ranged between 8 and 10 s, in order to avoid 
post-activation H-reflex depression (Crone & Nielsen, 1989). Stimulus intensity was 
increased gradually by steps of 2 mA until the descending part of the H-reflex 
recruitment curve was reached and by steps of 10 mA thereafter until the M-wave 
amplitude reached a plateau. Stimulation intensity was reassessed during the 
postcapsule test. When Mmax was reached, intensity of the electrical stimulation was 
decreased in order to evoke five control H-reflexes on the ascending portion of the 
recruitment curve preceded by a stable M-wave amplitude. For the measurement of VA 
and contractile properties, the intensity was set at 150% of Mmax and two squared-
pulses with a duration of 1 ms and an interstimulus interval of 10 ms were applied over 
the isometric force plateau and approximately 2 s after each MVC.  
 
Transcranial magnetic stimulation  
Magnetic stimuli were given with a concave double-cone coil (110-mm diameter) 
attached to a BiStim 2002 magnetic stimulator (Magstim Co.,  Dyfed, UK) to elicit MEPs 
in SOL. The coil was oriented to induce current in the posterior-to-anterior direction. 
Participants were seated in the sledge, as previously described, performing a low-
intensity sustained contraction. The hotspot of the SOL area of the motor cortex was 
identified in the familiarisation session by placing the centre of the coil 1 cm to the left 
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of the vertex and 1 cm posterior. The coil was then moved in 1 cm steps in the lateral-
medial and anterior posterior-directions to identify the optimal location. The hotspot 
was defined as the location eliciting the greatest SOL MEP amplitude. Upon 
identification, the hotspot was marked on the head with a permanent marker and the 
lateral-medial and anterior-posterior distances were measured for the upcoming 
sessions.  
 
MT was defined as the minimum intensity needed to evoke a MEP of > 200 μV in 3 out of 
5 trials in the tonically active SOL (Škarabot et al., 2016), and MT showed a very high 
level of day-to-day reliability (day-to-day CV of 4.40%) in our study.  
 
During the protocol, trains of 10 TMS pulses were used. Corticospinal excitability was 
examined by eliciting MEPs at a stimulus intensity of 130% of MT. The intracortical 
circuits measured were SICI and ICF with paired-pulse TMS, whereby a conditioning 
stimulus was delivered before the test stimulus. The conditioning stimulus intensity 
was 80% of MT, and the test stimulus intensity was 130% of MT. The interstimulus 
intervals were 2 ms during the blocks that assessed SICI and 12 ms during the blocks 
that assessed ICF (Sanger, Garg, & Chen, 2001). During the TMS trains, the interstimulus 
intervals randomly ranged between 5 and 10 s in order to avoid anticipation. To assess 
SP, single-pulse TMS was delivered while participants performed a voluntary 
contraction at 50% of MVC. Three trials were performed with an interval of 4s between 
trials at a test stimulus intensity of 130% of MT. 
 
Force 
Data were sampled at 1000 Hz via an A/D converter (CED 1401, Cambridge Electronics 
Design, Cambridge, UK) and low-pass filtered (cutoff frequency: 50 Hz). 
 
Electromyography  
Electromyographic (EMG) signals from SOL were recorded using an EISA 16-2 EMG 
system (EISA 16-2, University of Freiburg, Freiburg, Germany) and band-pass filtered 
(10-500 Hz). Oval-shaped, bipolar, pre-gelled silver chloride self-adhesive surface 
electrodes (AmbuBlueSensor N, Denmark, Ballerup) were placed over the mid-dorsal 
line of the posterior shank, below the gastrocnemius muscle. The inter-electrode 
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distance was 2 cm. To keep the inter-electrode resistance low (<2kΩ), the skin under 
the electrodes was shaved, abraded with sandpaper and swabbed with a 60% ethanol 
solution. Data were sampled at 1000 Hz (gain 500) via an A/D converter (CED 1401, 
Cambridge Electronics Design, Cambridge, UK). A permanent marker was used to mark 
the location of the EMG electrodes in the familiarisation session to ensure consistent 
electrode placement between sessions. 
 
Muscle soreness  
Participants self-reported soreness of the triceps surae muscle on the experimental 
days (right after the fatigue protocol and in the evening) and on the following 3 days (in 
the morning and in the evening). Participants were asked to draw a straight line on a 
visual analogue scale from 0-10 cm, where 0 represents no soreness and 10 maximal 
soreness. 
 
Blood samples  
Venus blood samples were collected immediately after the precapsule testing, 
immediately after the fatigue protocol and 6 h after the precapsule testing. Samples 
were collected into serum tubes using needles (Venosafe, Terumo Medical Co., Leuven, 
Belgium) for the basic blood count (Sysmex, XP300, Kobe, Japan) before the maximal 
test on the sledge apparatus. Whole blood was centrifuged at 2500 rpm (Megafuge 1.0R, 
Heraeus, Germany) for 10 min, after which serum was removed and stored at -80º C 
until analyses for serum caffeine and potassium (K+). 
 
Serum caffeine concentrations were assessed using high performance liquid 
chromatography (Agilent 1100 Series HPLC equipment, Santa Clara, USA). A 5 μm, 100 x 
4.6 mm reversed-phase C18 column and a 4.6 mm C18 guard cartridge insert 
(Phenemenex Kinetex, Phenomenex SecurityGuard ULTRA, Torrance, USA) were used. 
The mobile phase consisted of 1% acetic acid (A) and methanol (B). The mobile phase 
was degassed and delivered as a gradient (Methanol 15% to 40%) with a flow rate of 1 
ml/min and a pressure of 120 to 150 bar. Absorbance was monitored at 280 nm and at 
a sensitivity of 0.01 A, recording peak integrals. A standard curve was prepared for each 
set of samples using caffeine concentrations of 1.25, 2.5, 5.0, and 10.0 mg/l. Standards 
were prepared by diluting 100 mg/l caffeine in 1% acetic acid with serum from 
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individuals who had abstained from methylxanthines for 3 days. Caffeine was extracted 
from standards and serum samples using solid phase extraction columns (Phenomenex 
Strata C18-E, Torrance, USA) according to the manufacturer’s instructions. Columns 
were conditioned by passing 1 ml of methanol and 2x1 ml of distilled water through 
them under vacuum. 200 μl of serum was applied and after 1 min drawn through the 
column under vacuum. After an equilibration period of 2 min the columns were washed 
with 2x1 ml of distilled water. Caffeine was eluted with 400 μl of methanol. The solvent 
was evaporated under nitrogen and the residue was reconstituted in 400 μl of mobile 
phase. K+ was assessed by the spectrophotometric method with Konelab 20 XTi 
(Thermo Fisher Scientific, Vantaa, Finland).  
 
Data analysis  
The main researcher was blinded to the experimental condition and performed all 
analyses of the raw data. Peak-to-peak amplitude of H-reflexes, M-waves, MEPs and the 
twitch following the MVCs (potentiated twitch, PTw), as well as VA and the greatest 
force value during MVCs were obtained through automated analysis in Spike 2 software 
(v6.17, Cambridge Electronic Design Limited, Cambridge, UK). Duration of SP was 
manually analysed in the same software. After decoding, the data obtained in each 
experimental session were grouped for statistical analysis.  
 
H-reflexes and M-waves. The highest peak-to-peak amplitude of the H-reflex during the 
recruitment curve was determined and normalised to the peak-to-peak amplitude of 
Mmax. Immediately before and after the fatigue protocol and during the recovery 
period, the H-reflex was taken as the average of the five control H-reflexes that were 
evoked with a concomitant stable M-wave, and normalised to the Mmax evoked at that 
time-point. The concomitant evoked M-wave was 7.6 ± 4.3% of Mmax on the placebo 
day and 7.4 ± 3.8% on the caffeine day. The Mmax value used for analysis from the pre 
and postcapsule measurements was the highest value evoked either during the 
recruitment curve protocol or before MVCs.  
 
Motor evoked potentials (MEPs). Peak-to-peak unconditioned MEP amplitude (single 
pulse stimulation) were averaged from each train of 10 stimuli and normalised to 
Mmax. Regarding the paired-pulse paradigm (SICI and ICF) in the pre and postcapsule 
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measurements, the average of the amplitudes of each conditioned test MEP was 
expressed as a percentage of the average MEP size (control MEP) of the train of single-
pulse stimuli from the same time-point.  
 
TMS-evoked silent period (SP). The duration of SP was measured from the end of the 
MEP evoked by the test stimulus to the resumption of any level of sustained EMG 
activity. SP onset and offset were identified by visual inspection. The presented SP is the 
average value of the three trials.  
 
Voluntary activation (VA) and contractile properties. VA was calculated with the linear 
equation VA (%) = [1 − (SIT/PTw)] × 100, according to the interpolated twitch 
technique, where SIT is the amplitude of the superimposed twitch and PTw is the 
amplitude of the potentiated twitch evoked at rest after MVC. VA presented from the pre 
and postcapsule measurements are the averaged value of the three trials. To examine 
contractile properties, PTw was analysed. 
 
Force and rate of force development (RFD). MVC peak was defined as the greatest force 
achieved before the stimulation. In the pre and postcapsule measurements, the highest 
MVC peak was considered. RFD was assessed by analysing the average slope values of 
the force/time curve over time intervals of 0-100 and 0-200 ms, starting from the onset 
of contraction (identified through automated analysis in Spike 2 software), as well as 
the maximum instantaneous ascending rate of force development (RFDmax). For the 
analysis of RFD in the pre and postcapsule measurements, the trial with the highest 
RFDmax was considered.  
 
Squat and drop jump performance. Jump height was determined by subtracting the 
participant’s relative standing height on the sledge from the highest position of the 
sledge odometer, which was determined by visual inspection in each jump. The best 
trial was considered.  
 
Statistical analysis  
Data were presented as means ± standard deviations. Statistical analysis was performed 
using SPSS (v20, SPSS Inc., Chicago, IL, USA). Statistical significance was set at an alpha 
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level of 0.05. Normality of the data was examined using Shapiro-Wilk test. For VA, the 
combinations of the independent variables were normally distributed after an arc-sin 
transformation of the square root of the raw values [arsin (sqrt (raw value)) – 0.2854]. 
The two-tailed paired Student’s t test was used to analyse the effects of caffeine on the 
number of sets completed in the fatigue protocol. Pre to postcapsule data, as well as 
fatigue and recovery data were analysed using repeated measures ANOVA, with time 
and drug as independent factors. Additionally, exploratory analysis was conducted 
through repeated measures mixed ANOVA, which was used to investigate differences 
between two subgroups of the current sample. These subgroups were identified 
through a k-means cluster analysis, based on the placebo to caffeine change in the 
number of sets during the fatigue protocol. To determine the optimal number of 
clusters, k-means clustering were initially computed for different values of k. For each 
value of k, the squared average distance of each point within a cluster to the cluster 
centroid was calculated and then averaged across all clusters. The lowest mean value 
across clusters was then used to determine the optimal value of k. Least Significant 
Difference (LSD) method was utilised for post hoc comparisons. For all ANOVAs, 
sphericity was assessed using Mauchly’s test of sphericity. When sphericity was 
violated, Greenhouse-Geisser correction was employed. 
Effect sizes were reported as Cohen’s dz for the t test, and as partial eta squared (ƞp2) for 
ANOVAs. Magnitudes of dz were interpreted using the following thresholds: trivial, < 
0.2; small, 0.2– 0.6; moderate, 0.6–1.2; large, 1.2–2.0; or very large, > 2.0. Regarding 
correlations, Pearson product-moment correlation was used when data were normally 
distributed and Spearman’s rank order correlation for non-normally distributed data. 
 
Data availability 
Non-identifiable datasets generated during and/or analysed during the current study 
are available from the corresponding author on reasonable request. 
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RESULTS 
 
Plasma values of caffeine 
 
Blood analysis revealed a non-existence of caffeine in the blood stream prior to capsule 
administration. Caffeine increased over time during caffeine trials [F(1.858; 31.582) = 
368.785, p < 0.001, ƞp2 = 0.956], reaching an average peak level (p < 0.001) of 8.51 mg/l 
(range: 7.22 – 10.94) 60 min after capsule ingestion. Immediately after the fatigue 
protocol [7.04 (5.38 – 9.02)] and 6 h after ingestion [4.77 (1.78 – 7.02)] it was 
significantly decreased (p < 0.001 for both pairwise comparisons). Large inter-
individual variability was observed in plasma caffeine levels throughout the protocol. 
Nevertheless, the degree of responsiveness to caffeine in the fatigue protocol (number 
of sets performed, as % change from placebo) was not significantly correlated with 
caffeine plasma values either 60 min after ingestion (r = 0.10, p = 0.693) or immediately 
after exhaustion (r = 0.24, p = 0.345). Participants finished the fatigue protocol 
approximately 3 h after ingestion of the caffeine capsule [196 ± 29 min]. 
 
Pre- to postcapsule measurements 
 
Exercise performance variables 
Analysis of variance revealed no significant main effect of time (p = 0.403), drug (p = 
0.529) or interaction between these two factors (p = 0.476) for MVC [Precapsule on the 
placebo day (PREPLA): 1918.6 ± 345.1 N, Postcapsule on the placebo day (POSTPLA): 
1962.4 ± 374.4 N, Precapsule on the caffeine day (PRECAFF): 1893.0 ± 347.9 N, 
Postcapsule on the placebo day (POSTCAFF): 1898.3 ± 401.6 N]. Similarly, there was no 
significant effect of time, drug or time*drug for RFD0-200 (PREPLA: 5086.3 ± 1451.9 N·s-1, 
POSTPLA: 5208.4 ± 1403.2 N·s-1, PRECAFF: 4676.3 ± 2077.5 N·s-1, POSTCAFF: 4875.9 ± 
2059.8 N·s-1). RFD0-100 and RFDMAX behaved in the same way. Squat jump height was 
increased after capsule ingestion [F(1;17) = 4.825, p = 0.042, ƞp2 = 0.221], but no 
significant main effect of drug (p = 0.176) or time*drug (p = 0.460) were found 
(PREPLA: 78 ± 8 cm, POSTPLA: 79 ± 7 cm, PRECAFF: 79 ± 9 cm, POSTCAFF: 81 ± 9 cm).  
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For drop jump height a significant main effect of drug was not observed (p = 0.309). 
However, there was a significant effect of time [F(1;17) = 11.064, p = 0.004, ƞp2 = 0.394] 
and a significant time*drug effect [F(1;17) = 59.587, p = 0.001, ƞp2 = 0.485]. Post-hoc 
analysis (Figure 2A) revealed a significant 4.2 ± 3.7% improvement after caffeine 
administration (93 ± 9 cm vs 97 ± 10 cm, p < 0.001) which was not observed in the 
placebo trial [93 ± 10 cm vs 94 ± 11 cm, p = 0.704].  
 
H-reflex 
Analysis of variance revealed no significant main effect of time (p= 0.202), drug (p = 
0.493) or time*drug interaction (p = 0.485) on H-max (PREPLA: 53.8 ± 15.3%, 
POSTPLA: 54.7 ± 14.4%, PRECAFF: 55.4 ± 16.6%, POSTCAFF: 58.4 ± 15.9%). 
Transcranial magnetic stimulation measures 
Analysis of variance revealed no significant main effect of time (p = 0.780), drug (p = 
0.897) or time*drug interaction (p = 0.151) on MT (PREPLA: 36 ± 6%, POSTPLA: 35 ± 
5%, PRECAFF: 35 ± 7%, POSTCAFF: 36 ± 7%). No significant changes were found for the 
unconditioned MEP amplitude either (PREPLA: 12.3 ± 4.3%, POSTPLA: 11.7 ± 5.5%, 
PRECAFF: 12.3 ± 5.6%, POSTCAFF: 11.3 ± 5.0%), regarding time (p = 0.950), drug (p = 
0.110) or time*drug (p = 0.756). Regarding SICI, there was no significant main effect of 
drug (p = 0.431) or time*drug (p = 0.418). However, the amplitude of the conditioned 
MEP was significantly higher in the postcapsule measurement for both conditions, 
[F(1;17) = 12.869, p = 0.002, ƞp2 = 0.431, PREPLA: 32.0 ± 14.3%, POSTPLA: 38.2 ± 
16.8%, PRECAFF: 31.3 ± 12.9%, POSTCAFF: 34.2 ± 13.2%]. On average, the protocol to 
induce ICF did not elicit a facilitated conditioned MEP (PREPLA: 60.3 ± 25.1%, 
POSTPLA: 64.7 ± 32.8%, PRECAFF: 47.1 ± 20.3 %, POSTCAFF: 53.7 ± 21.3%). ANOVA for 
ICF did not reveal a significant effect of time (p = 0.215), drug (p = 0.052), or time*drug 
interaction (p = 0.818).  A significant effect of drug (p = 0.682) was not observed for SP. 
However, there was a significant effect of time [F(1;16) = 5.142, p = 0.038, ƞp2 = 0.243] 
and a significant effect of time*drug [F(1;16) = 10.764, p = 0.005, ƞp2 = 0.402]. Post-hoc 
analysis revealed a significant 12.6 ± 12.7% decrease of SP after caffeine ingestion (78 ± 
17 vs 67 ± 12 ms, p = 0.002) which was not observed in the placebo condition (71 ± 15 
vs 72 ± 16 ms, p = 0.854) (Figure 2B). Further analysis revealed that the exclusion of an 
outlier who showed a ~70% increment of the SP on the placebo day did not affect the 
pattern of the aforementioned results. 
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[INSERT FIGURE 2 HERE] 
 
Voluntary activation and potentiated twitch 
Analysis of variance revealed no significant main effect of time (p= 0.613), drug (p = 
0.179) or time*drug interaction (p = 0.496) on VA, which ranged from 95 to 100%. 
Pooled placebo and caffeine data revealed that PTw was significantly potentiated 
following three MVCs (p = 0.006, ƞp2 =0.368), but caffeine had no effect on the degree of 
potentiation. 
Fatigue protocol and recovery 
On average, the number of sets completed in the fatigue protocol was not significantly 
different between conditions, with a moderate effect size favouring caffeine [t(17) = -
1.474, p = 0.159, dz = 0.347] between placebo (7 ± 5) and caffeine (8 ± 6)]. However, a 
k-means clustering approach was used, revealing that the lowest within-cluster sum of 
squares was observed for k = 3, with a cluster of participants who did not benefit from 
caffeine ingestion or with a trivial magnitude of response (n = 8, range: -29.4 to 2.4% of 
change from placebo to caffeine), a cluster of participants with a considerable 
improvement on the caffeine day (n = 9, range: 11.20 to 74.29% change from placebo to 
caffeine), and a cluster with only one participant with a considerably higher level of 
responsiveness (141.5% change from placebo to caffeine), who was considered an 
outlier.  The remaining two subgroups were used as an independent variable for 
exploratory analysis. A significant effect of this between-subjects factor was observed 
only for Mmax and RPE, and is described below. Preliminary analysis revealed that the 
exclusion of the outlier in this exploratory analysis did not affect the pattern of results. 
Individual data regarding the relative change of the number of sets between conditions 
can be seen in Figure 3.  
 
The number of sets completed in the caffeine trial revealed a weak to moderate 
correlation with the pre to postcapsule caffeine-induced decrease in SICI (Figure 4A), as 
well as a significant moderate correlation with the pre- to postcapsule caffeine-induced 
decrease in SP (Figure 4B). The degree of responsiveness to caffeine (% change from 
placebo, regarding the number of sets performed) was not associated with the daily 
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habitual consumption of caffeine (r = 0.100, p = 0.693) or the order of trials. 
 
 [INSERT FIGURE 3 HERE] 
[INSERT FIGURE 4 HERE] 
 
Means and SDs of the neuromuscular measures presented below can be found in Table 
1.  
[INSERT TABLE 1 HERE] 
MVC remained depressed (Figure 5) throughout the fatiguing activity and recovery 
[F(2.360; 35.394) = 22.469, p < 0.001, ƞp2 = 0.6], with no significant main effect of drug 
(p = 0.129) or time*drug interaction (p = 0.814). Similarly, there was a significant main 
effect of time [F(6;90) = 8.213, p < 0.001, ƞp2 = 0.354], but not drug (p = 0.082) or 
time*drug (p = 0.249) for RFD0-200. Analysis of variance for RFD0-100 and RFDMAX 
revealed the same, with a decline of RFD during fatigue and recovery. 
 
Regarding VA, ANOVA revealed a significant main effect of time [F(2.924;40.937) = 
6.683, p = 0.001, ƞp2 = 0.323] but not drug (p = 0.847) or time*drug (p = 0.411). A 
significant main effect of time was also found for PTw [F(6;90) = 9.089, p <0.001, ƞp2 = 
0.377,], with no significant main effect of drug (p = 0.861) or time*drug (p = 0.861). VA 
and PTw were significantly depressed at exhaustion and throughout recovery (Figure 
5). 
 
[INSERT FIGURE 5 HERE] 
 
Mmax was significantly depressed during fatigue and recovery. [F(2.142;29.991) = 
10.614, p < 0.001, ƞp2 = 0.431], with no significant effect of drug (p = 0.241) or 
time*drug (p = 0.591). Notably, a significant interaction effect between time, drug and 
the two subgroups of participants was found for this variable in the repeated measures 
mixed ANOVA [F(2.938;38.196) = 2.761, p = 0.005, ƞp2 = 0.277] (Figure 6).  
 
[INSERT FIGURE 6 HERE] 
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Analysis of variance revealed no significant main effect of time (p = 0.07), drug (p = 
0.895) or time*drug interaction (p = 0.378) for the MEP amplitude. SP was 11% lower 
at task failure, and remained depressed during the early stage of recovery 
[F(3.011;39.138) = 3.793, p = 0.018, ƞp2 = 0.226], with no effect of drug (p = 0.869) or 
interaction between these two factors (p = 0.577). Analysis of variance revealed no 
significant main effect of time (p= 0.514), drug (p = 0.761) or time*drug (p = 0.832) for 
the H-reflex measured in the ascending part of the recruitment curve.  
 
Regarding RPE, ANOVA showed a significant main effect of time [F(1.172;15.236) = 
28.515, p < 0.001, ƞp2 = 0.687] and drug [F(1;13) = 5.698, p = 0.033, ƞp2 = 0.305], but no 
significant interaction (p = 0.297). RPE increased throughout the protocol and pooled 
data from all time-points revealed significantly lower values in the caffeine condition in 
the first 3 sets (Figure 7). Furthermore, mixed ANOVA showed that this significant 
caffeine-induced lower RPE was observed in the subgroup of participants who 
responded to caffeine (p = 0.006), but not in the other participants with a trivial benefit 
or with a performance impairment on the caffeine day (p = 0.534). 
 
[INSERT FIGURE 7 HERE] 
 
Analysis of variance on [K+] revealed no significant effect of time (p = 0.07) and no 
significant interaction effect (p = 0.207). A significant effect of drug was, however, 
observed [F(1;17) = 13.679, p = 0.002, ƞp2 = 0.446]. In the caffeine trial, [K+] was 
significantly lower [4.091 ± 0.245 vs. 3.922 ± 0.271 mmol/l, placebo and caffeine 
conditions for the pooled pre and postfatigue data].  
 
For muscle soreness, there was a significant main effect of time [F(2.729;43.665) = 
21.546, p < 0.001, ƞp2 = 0.574], session [F(1;16) = 13.997, p = 0.002, ƞp2 = 0.467] and a 
significant interaction between them [F(2.064;33.019) = 5.078, p = 0.011, ƞp2 = 0.241]. A 
delayed onset of muscle soreness (DOMS) was observed after both sessions and 
attenuated after the second session, in a time-window between the following morning 
and 2 days later in the evening (+1 day morning: 4.9 ± 2.8 vs 3.3 ± 2.3, +1 day evening: 
5.0 ± 2.8 vs 3.5 ± 2.5, +2 days morning: 4.9 vs 2.4 vs 2.6 ± 2.1, + 2 days evening: 3.5 ± 2.1 
vs 2.0 ± 1.8). 
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The aim of the present study was to investigate the underlying neuromuscular 
mechanisms that may be responsible for any caffeine-induced ergogenic effects in a 
non-fatigued state and during fatiguing stretch-shortening cycle exercise (SSC). In this 
randomised, double-blind, placebo-controlled crossover trial, it was found that in a non-
fatigued state, caffeine enhanced drop jump height and decreased inhibition at the 
cortical and/or spinal level, as revealed by the SP duration. Although caffeine 
administration did not significantly increase the number of sets completed during the 
fatiguing SSC task when looking at the averaged data, a high level of inter-individual 
variability was observed. Caffeine did not affect the decline of MVC and RFD at 
exhaustion and did not potentiate recovery in the fatigue protocol. Central and 
peripheral fatigue, demonstrated throughout the fatiguing protocol and recovery, were 
also not attenuated by this psychoactive drug. Nonetheless, the present study shows an 
association between pre to postcapsule caffeine-induced changes in the CNS and a 
subsequent improvement of exercise performance. Furthermore, the subgroup of 
participants who responded to caffeine benefited from a decreased sense of effort 
during the activity and an accelerated recovery of Mmax after fatiguing exercise. 
 
In a non-fatigued state caffeine improved drop jump height, but not squat jump height, 
MVC or RFD.  
Caffeine administration enhanced SSC performance (drop jump) by 4.2 ± 3.7% without 
a significant ergogenic effect on isometric performance (MVC and RFD) or concentric 
performance (squat jump). It could be hypothesized that the known effects of this 
psychoactive drug on vigilance (Koelega, 1993), sustained attention (Lorist & Tops, 
2003) and arousal (Barry et al., 2009), as well as on inhibitory and excitatory central 
mechanisms that were shown in the present study, may explain its selective 
ergogenicity in intensive and complex tasks (e.g. rebounding as high as possible after 
being dropped from a certain height), without an ergogenic association in tasks with 
less complexity (e.g. performing a squat jump). Previous studies (Del Coso et al., 2014; 
Abian et al., 2015; Pérez-López et al., 2015; Bloms et al., 2016) have actually shown an 
increased squat jump height after caffeine ingestion. However, these studies did not 
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include a precapsule measurement and, therefore, these data should be interpreted 
with caution, as day-to-day variability was not controlled (for example, in our study 
squat jump height had a day-to-day CV of 5.2%). 
 
Effects of caffeine on the central nervous system in a non-fatigued state and during the 
fatigue protocol 
The antagonism of adenosine receptors in the CNS is consistently identified as the 
leading hypothesis to explain the ergogenic effects of caffeine.  In the present study, pre 
to postcapsule changes in the CNS were associated with a subsequent improvement of 
exercise performance.  In a non-fatigued state, caffeine administration resulted in a 
significant 12.6 ± 12.7% decrease of SP, which was not observed in the placebo 
condition. SP has usually been used as a measure of intracortical inhibition that is 
activated by long-lasting GABAB receptors (McDonnell, Orekhov, & Ziemann, 2006). 
More recently (Škarabot, Mesquita, Brownstein, & Ansdell, 2019) it has been suggested 
that both cortical and spinal inhibitory mechanisms may contribute to the SP duration. 
Cerqueira et al (2006) found a decrease in this measure in the biceps brachii and 
abductor digiti minimi which was similar to the present study, whereas Orth et al. 
(2005) found an unaltered SP in the first dorsal interosseus muscle. This inconsistency 
may be attributed to the use of different doses of caffeine, different muscles under 
investigation, as well as different methodological procedures used to examine SP.  
 
All these confounding factors may also explain the divergent results regarding fatigue-
induced changes of SP. In the present study, SP was decreased in both conditions 
throughout fatigue, reaching a value which was 11% lower at task failure, and remained 
depressed during the early stage of recovery. Thus, it is very likely that the participants 
experienced a fatigue-induced decrease in cortical and/or spinal inhibition. However, 
there are some limitations and confounding factors associated with this measure that 
should be acknowledged. It is possible that fatigue-induced changes in neural drive may 
have modulated SP duration. However, this is unlikely given that participants were 
asked to perform a submaximal contraction which reached a force level that was 
relative to the new MVC. Furthermore, most studies have actually been unable to 
demonstrate a relationship between neural drive and duration of SP (e.g. Säisänen et al., 
2008). In the present experiment, SP was analysed from the end of MEP, as suggested by 
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Säisänen et al. (2008), in order to reflect the period solely marked by inhibitory 
influence. Another option would have been to use a relative SP measured from the onset 
of MEP or from the TMS delivery (Škarabot et al., 2019). Although a significant change in 
the MEP amplitude was not found in this study after fatigue, it should be remembered 
that any changes in the characteristics of MEP associated with fatigue might influence 
the duration of SP to some extent. However, it is important to note that the exact time-
point of the start of the inhibitory mechanisms that explain SP and the beginning of the 
excitatory mechanisms reflected in the onset of MEP may not coincide. Nevertheless, a 
similar behaviour has been observed in previous studies (Girard, Bishop, & Racinais, 
2013; Kirk, Trajano, Pulverenti, Rowe, & Blazevich, 2019; Latella, Hendy, 
Vanderwesthuizen, & Teo, 2018; Mira et al., 2017). We hypothesize that this 
suppression of inhibitory mechanisms may be the expression of a compensatory 
phenomenon to try to overcome a deficit of VA which was observed throughout the 
fatiguing protocol and recovery. 
 
Carvalho et al. (2010) showed a decrease of SP (of around 17%) after a 2-min MVC in 
the caffeine condition which was not observed in the placebo trial. Although caffeine did 
not have an influence on the changes of SP during fatigue and recovery in the present 
study, the caffeine-related decline of SP prior to the fatiguing exercise was associated 
with a better performance in the caffeine trial.  It is possible that the observed 
shortening of SP in a non-fatigued state after caffeine ingestion, as well as after the 
fatigue protocol, may be due to a decrease of the long-lasting activity of cortical 
GABAergic neurons (Krnjević, Randić, & Straughan, 1966). However, other mechanisms 
of spinal origin cannot be ruled out (Škarabot et al., 2019). 
 
The relationship between suppression of inhibitory mechanisms prior to exercise and 
subsequent exercise performance was further corroborated by a weak to moderate 
correlation between the pre to postcapsule caffeine-induced decrease in SICI and the 
number of sets completed in the caffeine trial. SICI is a form of inhibition that is 
modulated by the activation of GABAA receptors within the primary motor cortex 
(Ziemann, Lönnecker, Steinhoff, & Paulus, 1996). To the best of our knowledge, this is 
the first time that a caffeine-induced decrease of inhibitory mechanisms in the CNS is 
associated with subsequent exercise performance. At the group level, however, caffeine 
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did not influence the pre to postcapsule decrease in SICI, which is consistent with data 
obtained by Orth et al. (Orth et al., 2005) and Carvalho et al. (2010). 
 
Surprisingly, when using the ICF protocol, the amplitude of the conditioned MEP was 
lower than the amplitude of the unconditioned MEP. This has also been observed earlier 
(e.g. Brownstein et al., 2018). Previous studies did not show a significant effect of 
caffeine on intracortical excitatory mechanisms (de Carvalho et al., 2010; Orth et al., 
2005), but we cannot be sure that we were, in fact, testing this association due to our 
inability to induce an average ratio of conditioned/unconditioned MEP amplitude above 
100%. The cortical mechanisms underlying ICF are not yet fully understood, but it has 
been suggested that it concurrently results from excitatory glutamatergic responses and 
from weak GABAA inhibitory responses (Ziemann et al., 1996). These results challenge 
the validity and applicability of investigating intracortical excitatory mechanisms in the 
SOL.  
 
As expected, caffeine had no effect on MT. This is in agreement with previous studies 
(Cerqueira et al., 2006; de Carvalho et al., 2010; Orth et al., 2005). We also did not 
observe a caffeine-induced effect on the MEP amplitude during a non-fatigued state, 
which is consistent with earlier studies (Cerqueira et al., 2006; de Carvalho et al., 2010; 
Kalmar & Cafarelli, 2004; Orth et al., 2005). 
 
Central fatigue experienced by our participants, reflected by a marked decrease of VA 
throughout fatigue and recovery, was not attenuated by caffeine ingestion. Such an 
attenuation has only been reported once (Del Coso et al., 2008), which is in contrast 
with a considerable number of studies (Cureton et al., 2007; Eaton et al., 2016; Kalmar 
& Cafarelli, 2006; Kalmar et al., 2006; Meyers & Cafarelli, 2005; Smirmaul et al., 2016). 
 
In this study, caffeine had no effect on the size of the H-reflex. This is consistent with 
data obtained by Kalmar et al. (2006) and by Behrens and colleagues (Behrens, Mau-
Moeller, Heise et al., 2015; Behrens, Mau-Moeller, Weippert et al., 2015) but contrary to 
other studies where an enhancement of the peak-to-peak maximal normalised H-reflex 
(Kalmar & Cafarelli, 1999) and of the normalised slope of the H-reflex recruitment curve 
(Walton et al., 2003) were observed. Walton et al. (2002) also showed an effect of 
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caffeine on the strength of persistent inward current activity of spinal motoneurons. 
Further research should further elucidate the effects of caffeine on spinal mechanisms. 
Kalmar et al. (2006) observed a protective effect of caffeine on the decline of alpha 
motoneuron excitability after fatigue, but this measure was unaltered in the current 
study. Consistent with our findings, Boerio et al. (2005) and Laurin et al. (2012) also did 
not observe significant changes after fatigue. H-reflexes may not be attributed to a 
single and isolated spinal mechanism (Zehr, 2002), and other approaches may be more 
sensitive to examine the effects of caffeine and fatigue on spinal excitability (e.g. 
cervicomedullary motor-evoked potentials - CMEPs). Unlike the evoked H-reflex, CMEPs 
are not affected by presynaptic inhibition (Nielsen & Petersen, 1994). 
 
Caffeine did not affect contractile properties 
As expected, caffeine did not have an effect on contractile properties. An extensive 
number of studies in vivo have corroborated the implausibility of peripheral ergogenic 
effects of caffeine (e.g. Neyroud et al., 2019), with only three studies showing an 
attenuated decrease of contractile measures during fatigue (Bazzucchi et al., 2011; 
Cureton et al., 2007; Meyers & Cafarelli, 2005), and another study showing an offset of 
the decline of low-frequency tetanic force (Tarnopolsky & Cupido, 2000). 
 
Caffeine enhanced the recovery of neuromuscular transmission, but only in responders 
To the best of our knowledge, this is the first study to show an effect of caffeine on the 
recovery of neuromuscular transmission after fatiguing SSC exercise, which was 
accelerated only in the subgroup of participants who had a considerable improvement 
on the caffeine day. The fatiguing task resulted in a significant reduction of Mmax, which 
remained supressed in those who did not considerably enhance their performance on 
the caffeine day but recovered to baseline values in those who did. These findings 
further support the idea of a caffeine-related enhancement of peripheral neuromuscular 
transmission which has previously been observed through an attenuation of plasma K+ 
levels (Lindinger et al., 1993), attenuated muscle interstitial K+ levels (Mohr et al., 
2011), as well as a better preservation of Mmax at task failure (Bowtell et al., 2018). A 
caffeine-induced effect on peripheral membrane excitability would attenuate 
postsynaptic neuromuscular transmission failure and possibly prevent other K+ 
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mediated mechanisms, such as failure of axonal propagation of action potentials 
(Adelman, Palti, & Senft, 1973) and activation of small diameter group III-IV afferents 
(Rybicki, Waldrop, & Kaufman, 1985), with a possible inhibitory effect on the CNS 
(Taylor, Amann, Duchateau, Meeusen, & Rice, 2016) in some motoneuron pools. The 
current caffeine-related findings on recovery of neuromuscular transmission are partly 
corroborated by an observed significant main effect of drug on plasma levels of [K+], 
which were attenuated in the caffeine condition. Although a significant interaction effect 
of time*drug with a caffeine-related attenuation of K+ accumulation in the blood stream 
would be expected, it could be argued that intravenous blood samples are an indirect 
measure which cannot directly translate what is occurring within the muscle. This has 
been demonstrated by Mohr et al. (2011), where plasma [K+] was not a sensitive 
measure of muscle interstitial [K+] changes. In fact, it is likely that an efflux of K+ into the 
blood stream resulted in an uptake of K+ into inactive tissues (e.g. resting muscles), as 
noted by Lindinger et al. (1990). 
 
Effects of caffeine on sense of effort 
Interestingly, those with a considerable improvement of performance during the fatigue 
protocol on the caffeine day demonstrated a caffeine-induced attenuated sense of effort 
during the first 3 trials of the fatigue protocol, whereas the other subgroup of 
participants did not benefit from this effect.  Perception of effort may be modulated 
through the effects of caffeine on adenosine receptors (Doherty and Smith, 2005) at 
multiple sites of the CNS. Caffeine might have influenced the neurocognitive processing 
of corollary discharges from premotor and motor areas of the cortex, which would be 
consistent with data obtained by de Morree et al. (2014) who showed an association 
between caffeine ingestion and a reduction in the activity of cortical premotor and 
motor areas. Alternatively, caffeine could also have modulated the afferent feedback 
from group III/IV muscle afferents (Amann et al., 2010). Although the participants of 
the current study received exercise-specific instructions about how to rate perception 
of effort, we cannot absolutely rule out the possibility of inclusion of other exercise-
related sensations in their rating of effort, such as muscle pain or the fatigue-related 
burning sensation in the muscles. As humans are able to dissociate between perceptual 
physical effort and perception of pain (O’Connor & Cook, 2001), further research should 
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be carried out to examine the effects of caffeine on perception of effort and other 
sensations related to physical exercise with specific psychophysical scales. 
 
Repeated bout effect was observed after 14 days 
In this randomised, double-blind, placebo-controlled crossover trial, a lower amount of 
muscle soreness following the second session was observed. This protective effect 
against muscle damage from a single bout of SSC exercise is known as the repeated bout 
effect (McHugh, 2003). As an interesting side-story, we found that a repeated bout effect 
can be verified after 14 days. 
 
Categorisation of sample participants according to the degree of responsiveness 
As group mean changes may not tell the whole story, an exploratory analysis based on 
k-means clustering was conducted, dividing our study sample into those with a 
considerably high improvement on the caffeine day and those with a trivial benefit or 
with a performance impairment. Although such an approach has been used before to 
identify clusters of individuals with different degrees of responsiveness (Bamman, 
Petrella, Kim, Mayhew, & Cross, 2007), a note of caution is due here as this classification 
could have led to false inferences about individuals who are deemed to respond/not 
respond to caffeine, due to within-subject variation between the two sessions. Future 
research could explore differences of neuromuscular mechanisms between responders 
and non-responders to caffeine with larger sample sizes and more robust sample 
responder counting that would take into consideration, for example, a measurement 
error statistic of the performance measure [e.g. 2 x the “typical error” (Ross, de Lannoy, 
& Stotz, 2015)]. In the current study, this approach could not be used. 
 
Conclusions 
This study elucidates the mechanisms of action of caffeine that may explain its 
ergogenic effects on exercise performance and contributes to a better understanding of 
neuromuscular changes during fatiguing activity. A caffeine dose of 6 mg·kg-1 improves 
drop jump height in a non-fatigued state and decreases SP. A caffeine-induced decrease 
of inhibitory mechanisms seems to be associated with increased performance in 
subsequent exercise. Those who benefit from caffeine ingestion experience a lower 
sense of effort during the exercise and an accelerated recovery of M-wave amplitude. 
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Ergogenic effects of caffeine are highly dependent on individual responsiveness and 
thus investigation of the effects of this drug on an individual basis is highly 
recommended. Further research could explore the effect of caffeine on the modulation 
of intracortical mechanisms during fatiguing exercise, as well as better describe the 
relationship between genetic polymorphisms and inter-individual variation in the 
response to caffeine and its neuromuscular effects. 
 
Acknowledgements 
We thank Professor Jayne Kalmar for her insightful feedback in critically reviewing the 
manuscript and Mr. Risto Puurtinen for his valuable assistance with blood collection 
and analysis. We also thank Mr. Dimitrios Giarmenitis, Mr. Gonzalo Guerrero, Mr. Joel 
Restuccia, Mr. Santtu Seipäjärvi, Ms. Sini Hentilä, Mr. Stanislovas Grincevicius and Mr. 










Effects of caffeine on neuromuscular function   29 
This article is protected by copyright. All rights reserved. 
REFERENCES 
 
Abian, P., Del Coso, J., Salinero, J. J., Gallo-Salazar, C., Areces, F., Ruiz-Vicente, D., … Abian-
Vicen, J. (2015). The ingestion of a caffeinated energy drink improves jump 
performance and activity patterns in elite badminton players. Journal of Sports 
Sciences, 33(10), 1042–1050. https://doi.org/10.1080/02640414.2014.981849 
Adelman, W. J., Palti, Y., & Senft, J. P. (1973). Potassium ion accumulation in a periaxonal 
space and its effect on the measurement of membrane potassium ion conductance. 
The Journal of Membrane Biology, 13(1), 387–410. 
https://doi.org/10.1007/BF01868237 
Amann, M., Blain, G. M., Proctor, L. T., Sebranek, J. J., Pegelow, D. F., & Dempsey, J. A. 
(2010). Group III and IV muscle afferents contribute to ventilatory and 
cardiovascular response to rhythmic exercise in humans. Journal of Applied 
Physiology, 109(4), 966–976. https://doi.org/10.1152/japplphysiol.00462.2010 
Bamman, M. M., Petrella, J. K., Kim, J. S., Mayhew, D. L., & Cross, J. M. (2007). Cluster 
analysis tests the importance of myogenic gene expression during myofiber 
hypertrophy in humans. Journal of Applied Physiology, 102(6), 2232–2239. 
https://doi.org/10.1152/japplphysiol.00024.2007 
Barry, R. J., Clarke, A. R., Johnstone, S. J., Brown, C. R., Bruggemann, J. M., & van Rijbroek, 
I. (2009). Caffeine effects on resting-state arousal in children. International Journal 
of Psychophysiology, 73(3), 355–361. 
https://doi.org/10.1016/j.ijpsycho.2009.05.012 
Bazzucchi, I., Felici, F., Montini, M., Figura, F., & Sacchetti, M. (2011). Caffeine improves 
neuromuscular function during maximal dynamic exercise. Muscle & Nerve, 43(6), 
839–844. https://doi.org/10.1002/mus.21995 
Behrens, M., Mau-Moeller, A., Heise, S., Skripitz, R., Bader, R., & Bruhn, S. (2015). 
Alteration in neuromuscular function of the plantar flexors following caffeine 
ingestion. Scandinavian Journal of Medicine and Science in Sports, 25(1), e50–e58. 
https://doi.org/10.1111/sms.12243 
Behrens, M., Mau-Moeller, A., Weippert, M., Fuhrmann, J., Wegner, K., Skripitz, R., … 
Effects of caffeine on neuromuscular function   30 
This article is protected by copyright. All rights reserved. 
Bruhn, S. (2015). Caffeine-induced increase in voluntary activation and strength of 
the quadriceps muscle during isometric, concentric and eccentric contractions. 
Scientific Reports, 5(1), 10209. https://doi.org/10.1038/srep10209 
Black, C. D., Waddell, D. E., & Gonglach, A. R. (2015). Caffeine’s ergogenic effects on 
cycling: Neuromuscular and perceptual factors. Medicine and Science in Sports and 
Exercise, 47(6), 1145–1158. https://doi.org/10.1249/MSS.0000000000000513 
Bloms, L. P., Fitzgerald, J. S., Short, M. W., & Whitehead, J. R. (2016). The Effects of 
Caffeine on Vertical Jump Height and Execution in Collegiate Athletes. Journal of 
Strength and Conditioning Research, 30(7), 1855–1861. 
https://doi.org/10.1519/JSC.0000000000001280 
Boerio, D., Jubeau, M., Zory, R., & Maffiuletti, N. A. (2005). Central and peripheral fatigue 
after electrostimulation-induced resistance exercise. Medicine and Science in Sports 
and Exercise, 37(6), 973–978. 
https://doi.org/10.1249/01.mss.0000166579.81052.9c 
Bowtell, J. L., Mohr, M., Fulford, J., Jackman, S. R., Ermidis, G., Krustrup, P., & Mileva, K. N. 
(2018). Improved Exercise Tolerance with Caffeine Is Associated with Modulation 
of both Peripheral and Central Neural Processes in Human Participants. Frontiers in 
Nutrition, 5, 6. https://doi.org/10.3389/fnut.2018.00006 
Brownstein, C. G., Ansdell, P., Škarabot, J., Frazer, A., Kidgell, D., Howatson, G., … Thomas, 
K. (2018). Motor cortical and corticospinal function differ during an isometric squat 
compared with isometric knee extension. Experimental Physiology, 103(9), 1251–
1263. https://doi.org/10.1113/EP086982 
Burke, L. (2008). Caffeine and sports performance. Applied Physiology, Nutrition, and 
Metabolism. Retrieved from 
http://www.nrcresearchpress.com/doi/abs/10.1139/h08-130 
Cerqueira, V., de Mendonça, A., Minez, A., Dias, A. R., & de Carvalho, M. (2006). Does 
caffeine modify corticomotor excitability? Neurophysiologie Clinique, 36(4), 219–
226. https://doi.org/10.1016/j.neucli.2006.08.005 
Collomp, K., Ahmaidi, S., Chatard, J., Audran, M., & Prefaut, C. (1992). Applied Physiology 
Effects of caffeine on neuromuscular function   31 
This article is protected by copyright. All rights reserved. 
in trained and untrained swimmers. European Journal of Applied Physiology, 64, 
377–380. https://doi.org/10.1007/BF00636227. 
Crone, C., & Nielsen, J. (1989). Methodological implications of the post activation 
depression of the soleus H-reflex in man. Experimental Brain Research, 78(1), 28–
32. https://doi.org/10.1007/BF00230683 
Cureton, K. J., Warren, G. L., Millard-Stafford, M. L., Wingo, J. E., Trilk, J., & Buyckx, M. 
(2007). Caffeinated sports drink: Ergogenic effects and possible mechanisms. 
International Journal of Sport Nutrition and Exercise Metabolism, 17(1), 35–55. 
https://doi.org/10.1123/ijsnem.17.1.35 
Davis, J. K., & Green, J. M. (2009). Caffeine and anaerobic performance: ergogenic value 
and mechanisms of action. Sports Medicine, 39(10), 813–832. 
https://doi.org/10.2165/11317770-000000000-00000 
de Carvalho, M., Marcelino, E., & de Mendonca, A. (2010). Electrophysiological studies in 
healthy subjects involving caffeine. Journal of Alzheimer’s Disease : JAD, 20 Suppl 1, 
S63-9. https://doi.org/10.3233/JAD-2010-1377 
de Morree, H. M., Klein, C., & Marcora, S. M. (2014). Cortical substrates of the effects of 
caffeine and time-on-task on perception of effort. Journal of Applied Physiology, 
117(12), 1514–1523. https://doi.org/10.1152/japplphysiol.00898.2013 
Del Coso, J., Estevez, E., & Mora-Rodriguez, R. (2008). Caffeine effects on short-term 
performance during prolonged exercise in the heat. Medicine and Science in Sports 
and Exercise, 40(4), 744–751. https://doi.org/10.1249/MSS.0b013e3181621336 
Del Coso, J., Pérez-López, A., Abian-Vicen, J., Salinero, J. J., Lara, B., & Valadés, D. (2014). 
Enhancing physical performance in male volleyball players with a caffeine-
containing energy drink. International Journal of Sports Physiology and 
Performance, 9(6), 1013–1018. https://doi.org/10.1123/ijspp.2013-0448 
Doherty, M., & Smith, P. M. (2005). Effects of caffeine ingestion on rating of perceived 
exertion during and after exercise: A meta-analysis. Scandinavian Journal of 
Medicine and Science in Sports, 15(2), 69–78. https://doi.org/10.1111/j.1600-
0838.2005.00445.x 
Effects of caffeine on neuromuscular function   32 
This article is protected by copyright. All rights reserved. 
Doherty, M., Smith, P. M., Davison, R. C. R., & Hughes, M. G. (2002). Caffeine is ergogenic 
after supplementation of oral creatine monohydrate. Medicine and Science in Sports 
and Exercise, 34(11), 1785–1792. https://doi.org/10.1097/00005768-200211000-
00015 
Eaton, T. R., Potter, A., Billaut, F., Panchuk, D., Pyne, D. B., Gore, C. J., … Stepto, N. K. 
(2016). A Combination of Amino Acids and Caffeine Enhances Sprint Running 
Capacity in a Hot, Hypoxic Environment. International Journal of Sport Nutrition 
and Exercise Metabolism, 26(1), 33–45. https://doi.org/10.1123/ijsnem.2015-0108 
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig,  a, & Zvartau, E. E. (1999). Actions of 
caffeine in the brain with special reference to factors that contribute to its 
widespread use. Pharmacological Reviews, 51(1), 83–133. https://doi.org/0031-
6997/99/5101-0083$03.00/0 
Ganio, M., Klau, J., Casa, D., Amstrong, L., & Maresh, C. (2009). Effect of Caffeine on Sport-
Specific Endurance Performance: A Systematic Review. The Journal of Strength and 
Conditioning Research., 23(1), 315–324. 
https://doi.org/10.1519/JSC.0b013e31818b979a 
Girard, O., Bishop, D. J., & Racinais, S. (2013). Neuromuscular Adjustments of the 
Quadriceps Muscle after Repeated Cycling Sprints. PLoS ONE, 8(5), 1–9. 
https://doi.org/10.1371/journal.pone.0061793 
Graham, T E, & Spriet, L. L. (1991). Performance and metabolic responses to a high 
caffeine dose during prolonged exercise. Journal of Applied Physiology, 71(6), 2292–
2298. https://doi.org/10.1139/H08-130 
Graham, Terry E. (2001). Caffeine and Exercise. Sports Medicine, 31(11), 785–807. 
https://doi.org/10.2165/00007256-200131110-00002 
Green, J. M., Olenick, A., Eastep, C., & Winchester, L. (2017). Caffeine influences cadence 
at lower but not higher intensity RPE-regulated cycling. Physiology and Behavior, 
169, 46–51. https://doi.org/10.1016/j.physbeh.2016.11.007 
Grgic, J., Grgic, I., Pickering, C., Schoenfeld, B. J., Bishop, D. J., & Pedisic, Z. (2019). Wake 
up and smell the coffee: Caffeine supplementation and exercise performance - An 
Effects of caffeine on neuromuscular function   33 
This article is protected by copyright. All rights reserved. 
umbrella review of 21 published meta-analyses. British Journal of Sports Medicine, 
1–9. https://doi.org/10.1136/bjsports-2018-100278 
Guest, N., Corey, P., Vescovi, J., & El-Sohemy, A. (2018). Caffeine, CYP1A2 Genotype, and 
Endurance Performance in Athletes. Medicine & Science in Sports & Exercise, 50(8), 
1570-1578. https://doi.org/10.1249/MSS.0000000000001596 
Hespel, P., ‘t Eijnde, B. O., & Van Leemputte, M. (2002). Opposite actions of caffeine and 
creatine on muscle relaxation time in humans. Journal of Applied Physiology, 92(2), 
513-518 https://doi.org/10.1152/japplphysiol.00255.2001. 
Horita, T., Komi, P. V, Nicol, C., & Kyröläinen, H. (1996). Stretch shortering cycle fatigue: 
interactions among joint stiffness, reflex, and muscle mechanical performance in 
the drop jump. European Journal of Applied Physiology, 73, 393–403. 
https://doi.org/10.1007/BF00334415 
Kalmar, J. M., & Cafarelli, E. (2006). Central excitability does not limit postfatigue 
voluntary activation of quadriceps femoris. Journal of Applied Physiology, 100(6), 
1757–1764. https://doi.org/10.1152/japplphysiol.01347.2005 
Kalmar, J. M., Del Balso, C., & Cafarelli, E. (2006). Increased spinal excitability does not 
offset central activation failure. Experimental Brain Research, 173(3), 446–457. 
https://doi.org/10.1007/s00221-006-0383-0 
Kalmar, J M, & Cafarelli, E. (1999). Effects of caffeine on neuromuscular function. Journal 
of Applied Physiology, 87(2), 801–808. https://doi.org/10.1016/j.jns.2015.02.031 
Kalmar, Jayne M., & Cafarelli, E. (2004). Central fatigue and transcranial magnetic 
stimulation: Effect of caffeine and the confound of peripheral transmission failure. 
Journal of Neuroscience Methods, 138(1–2), 15–26. 
https://doi.org/10.1016/j.jneumeth.2004.03.006 
Kamimori, G. H., Somani, S. M., Knowlton, R. G., & Perkins, R. M. (1987). The effects of 
obesity and exercise on the pharmacokinetics of caffeine in lean and obese 
volunteers. European Journal of Clinical Pharmacology, 31(5), 595–600. 
https://doi.org/10.1007/BF00606637 
Kirk, B. J. C., Trajano, G. S., Pulverenti, T. S., Rowe, G., & Blazevich, A. J. (2019). 
Effects of caffeine on neuromuscular function   34 
This article is protected by copyright. All rights reserved. 
Neuromuscular Factors Contributing to Reductions in Muscle Force After Repeated, 
High-Intensity Muscular Efforts. Frontiers in Physiology, 10(June), 1–17. 
https://doi.org/10.3389/fphys.2019.00783 
Koelega, H. S. (1993). Stimulant drugs and vigilance performance: a review. 
Psychopharmacology, 111(1), 1–16. https://doi.org/10.1007/BF02257400 
Koonrungsesomboon, N., Khatsri, R., Wongchompoo, P., & Teekachunhatean, S. (2018). 
The impact of genetic polymorphisms on CYP1A2 activity in humans: a systematic 
review and meta-analysis. Pharmacogenomics Journal, 18(6), 760–768. 
https://doi.org/10.1038/s41397-017-0011-3 
Krnjević, K., Randić, M., & Straughan, D. W. (1966). An inhibitory process in the cerebral 
cortex. The Journal of Physiology, 184(1), 16–48. 
https://doi.org/10.1113/jphysiol.1966.sp007902 
Lane, J. D., Steege, J. F., Rupp, S. L., & Kuhn, C. M. (1992). Menstrual cycle effects on 
caffeine elimination in the human female. European Journal of Clinical 
Pharmacology, 43(5), 543–546. https://doi.org/10.1007/BF02285099 
Lara, B., Ruiz-Moreno, C., Salinero, J. J., & Coso, J. Del. (2019). Time course of tolerance to 
the performance benefits of caffeine. PLoS ONE, 14(1), 1–18. 
https://doi.org/10.1371/journal.pone.0210275 
Latella, C., Hendy, A., Vanderwesthuizen, D., & Teo, W.-P. (2018). The modulation of 
corticospinal excitability and inhibition following acute resistance exercise in males 
and females. European Journal of Sport Science, 18(7), 984-993. 
https://doi.org/10.1080/17461391.2018.1467489 
Laurin, J., Dousset, E., Carrivale, R., Grélot, L., & Decherchi, P. (2012). Recovery pattern of 
motor reflex after a single bout of neuromuscular electrical stimulation session. 
Scandinavian Journal of Medicine & Science in Sports, 22(4), 534–544. 
https://doi.org/10.1111/j.1600-0838.2010.01279.x 
Lindinger, M. I., Graham, T. E., & Spriet, L. L. (1993). Caffeine attenuates the exercise-
induced increase in plasma [K+] in humans. Journal of Applied Physiology (Bethesda, 
Md. : 1985), 74(3), 1149–1155. https://doi.org/10.1152/jappl.1993.74.3.1149 
Effects of caffeine on neuromuscular function   35 
This article is protected by copyright. All rights reserved. 
Lindinger, M. I., Heigenhauser, G. J. F., McKelvie, R. S., & Jones, N. L. (1990). Role of 
nonworking muscle on blood metabolites and ions with intense intermittent 
exercise. American Journal of Physiology - Regulatory Integrative and Comparative 
Physiology, 258(6), R1486-R1494. 
https://doi.org/10.1152/ajpregu.1990.258.6.r1486 
Lorist, M. M., & Tops, M. (2003). Caffeine, fatigue, and cognition. Brain and Cognition, 
53(1), 82–94. https://doi.org/10.1016/S0278-2626(03)00206-9 
McDonnell, M. N., Orekhov, Y., & Ziemann, U. (2006). The role of GABAB receptors in 
intracortical inhibition in the human motor cortex. Experimental Brain Research, 
173(1), 86–93. https://doi.org/10.1007/s00221-006-0365-2 
McHugh, M. P. (2003). Recent advances in the understanding of the repeated bout effect: 
the protective effect against muscle damage from a single bout of eccentric 
exercise. Scandinavian Journal of Medicine and Science in Sports, 13(2), 88–97. 
https://doi.org/10.1034/j.1600-0838.2003.02477.x 
Merton, P. A. (1954). Voluntary strength and fatigue. The Journal of Physiology, 123(3), 
553–564. https://doi.org/10.1113/jphysiol.1954.sp005070 
Meyers, B. M., & Cafarelli, E. (2005). Caffeine increases time to fatigue by maintaining 
force and not by altering firing rates during submaximal isometric contractions. 
Journal of Applied Physiology, 99(3), 1056–1063. 
https://doi.org/10.1152/japplphysiol.00937.2004 
Mira, J., Lapole, T., Souron, R., Messonnier, L., Millet, G. Y., & Rupp, T. (2017). Cortical 
voluntary activation testing methodology impacts central fatigue. European Journal 
of Applied Physiology, 117(9), 1845–1857. https://doi.org/10.1007/s00421-017-
3678-x 
Mohr, M., Nielsen, J. J., & Bangsbo, J. (2011). Caffeine intake improves intense 
intermittent exercise performance and reduces muscle interstitial potassium 
accumulation. Journal of Applied Physiology, 111(5), 1372–1379. 
https://doi.org/10.1152/japplphysiol.01028.2010 
Mora-Rodríguez, R., Pallarés, J. G., López-Gullón, J. M., López-Samanes, Á., Fernández-
Effects of caffeine on neuromuscular function   36 
This article is protected by copyright. All rights reserved. 
Elías, V. E., & Ortega, J. F. (2015). Improvements on neuromuscular performance 
with caffeine ingestion depend on the time-of-day. Journal of Science and Medicine 
in Sport, 18(3), 338–342. https://doi.org/10.1016/j.jsams.2014.04.010 
Neyroud, D., Cheng, A. J., Donnelly, C., Bourdillon, N., Gassner, A.-L., Geiser, L., … Place, N. 
(2019). Toxic doses of caffeine are needed to increase skeletal muscle contractility. 
American Journal of Physiology-Cell Physiology, 316(2), C246–C251. 
https://doi.org/10.1152/ajpcell.00269.2018 
Nielsen, J., & Petersen, N. (1994). Is presynaptic inhibition distributed to corticospinal 
fibres in man? The Journal of Physiology, 477(1), 47–58. 
https://doi.org/10.1113/jphysiol.1994.sp020170 
O’Connor, P. J., & Cook, D. B. (2001). Moderate-intensity muscle pain can be produced 
and sustained during cycle ergometry. Medicine and Science in Sports and Exercise, 
33(6), 1046–1051. https://doi.org/10.1097/00005768-200106000-00026 
Orth, M., Amann, B., Ratnaraj, N., Patsalos, P. N., & Rothwell, J. C. (2005). Caffeine has no 
effect on measures of cortical excitability. Clinical Neurophysiology, 116(2), 308–
314. https://doi.org/10.1016/j.clinph.2004.08.012 
Pérez-López, A., Salinero, J. J., Abian-Vicen, J., Valadés, D., Lara, B., Hernandez, C., … Del 
Coso, J. (2015). Caffeinated energy drinks improve volleyball performance in elite 
female players. Medicine and Science in Sports and Exercise, 47(4), 850–856. 
https://doi.org/10.1249/MSS.0000000000000455 
Pageaux, B. (2016). Perception of effort in Exercise Science: Definition, measurement 
and perspectives. European Journal of Sport Science, 16(8), 885–894. 
https://doi.org/10.1080/17461391.2016.1188992 
Parsons, W. D., & Neims, A. H. (1978). Effect of smoking on caffeine clearance. Clinical 
Pharmacology and Therapeutics, 24(1), 40–45. 
https://doi.org/10.1002/cpt197824140 
Plaskett, C. J., & Cafarelli, E. (2001). Caffeine increases endurance and attenuates force 
sensation during submaximal isometric contractions. Journal of Applied Physiology, 
91(4), 1535–1544. https://10.1152/jappl.2001.91.4.1535 
Effects of caffeine on neuromuscular function   37 
This article is protected by copyright. All rights reserved. 
Roelands, B., Buyse, L., Pauwels, F., Delbeke, F., Deventer, K., & Meeusen, R. (2011). No 
effect of caffeine on exercise performance in high ambient temperature. European 
Journal of Applied Physiology, 111(12), 3089–3095. 
https://doi.org/10.1007/s00421-011-1945-9 
Ross, R., de Lannoy, L., & Stotz, P. J. (2015). Separate Effects of Intensity and Amount of 
Exercise on Interindividual Cardiorespiratory Fitness Response. Mayo Clinic 
Proceedings, 90(11), 1506–1514. https://doi.org/10.1016/J.MAYOCP.2015.07.024 
Rybicki, K. J., Waldrop, T. G., & Kaufman, M. P. (1985). Increasing gracilis muscle 
interstitial potassium concentrations stimulate group III and IV afferents. Journal of 
Applied Physiology, 58(3), 936–941. https://doi.org/10.1152/jappl.1985.58.3.936 
Sabol, F., Grgic, J., & Mikulic, P. (2019). The effects of 3 different doses of caffeine on 
jumping and throwing performance: A randomized, double-blind, crossover study. 
International Journal of Sports Physiology and Performance, 14(9), 1170–1177. 
https://doi.org/10.1123/ijspp.2018-0884 
Säisänen, L., Pirinen, E., Teitti, S., Könönen, M., Julkunen, P., Määttä, S., & Karhu, J. (2008). 
Factors influencing cortical silent period: Optimized stimulus location, intensity 
and muscle contraction. Journal of Neuroscience Methods, 169(1), 231–238. 
https://doi.org/10.1016/j.jneumeth.2007.12.005 
Sanger, T. D., Garg, R. R., & Chen, R. (2001). Interactions between two different 
inhibitory systems in the human motor cortex. Journal of Physiology, 530(2), 307–
317. https://doi.org/10.1111/j.1469-7793.2001.0307l.x 
Škarabot, J., Alfonso, R. P., Cronin, N., Bon, J., Strojnik, V., & Avela, J. (2016). Corticospinal 
and transcallosal modulation of unilateral and bilateral contractions of lower limbs. 
European Journal of Applied Physiology, 116(11–12), 2197–2214. 
https://doi.org/10.1007/s00421-016-3475-y 
Škarabot, J., Mesquita, R. N. O., Brownstein, C. G., & Ansdell, P. (2019). Myths and 
Methodologies: How loud is the story told by the transcranial magnetic 
stimulation-evoked silent period? Experimental Physiology, 104(5), 635–642. 
https://doi.org/10.1113/EP087557 
Effects of caffeine on neuromuscular function   38 
This article is protected by copyright. All rights reserved. 
Skinner, T. L., Jenkins, D. G., Coombes, J. S., Taaffe, D. R., & Leveritt, M. D. (2009). Dose 
response of caffeine on 2000-m rowing performance. Medicine and Science in Sports 
and Exercise, 42(3), 571/576. https://doi.org/10.1249/MSS.0b013e3181b6668b 
Smirmaul, B. P. C., de Moraes, A. C., Angius, L., & Marcora, S. M. (2016). Effects of caffeine 
on neuromuscular fatigue and performance during high-intensity cycling exercise 
in moderate hypoxia. European Journal of Applied Physiology, 117(1), 27-38. 
https://doi.org/10.1007/s00421-016-3496-6 
Southward, K., Rutherfurd-Markwick, K. J., & Ali, A. (2018). The Effect of Acute Caffeine 
Ingestion on Endurance Performance: A Systematic Review and Meta–Analysis. 
Sports Medicine, 48(8), 1913-1928. https://doi.org/10.1007/s40279-018-0939-8 
Tarnopolsky, M., & Cupido, C. (2000). Caffeine potentiates low frequency skeletal 
muscle force in habitual and nonhabitual caffeine consumers. Journal of Applied 
Physiology, 89(5), 1719–1724. https://doi.org/ 10.1152/jappl.2000.89.5.1719 
Taylor, J. L., Amann, M., Duchateau, J., Meeusen, R., & Rice, C. L. (2016). Neural 
contributions to muscle fatigue: From the brain to the muscle and back again. 
Medicine and Science in Sports and Exercise, 48(11), 2294–2306. 
https://doi.org/10.1249/MSS.0000000000000923 
Walton, C, Kalmar, J., & Cafarelli, E. (2003). Caffeine increases spinal excitability in 
humans. Muscle & Nerve. Retrieved from 
http://onlinelibrary.wiley.com/doi/10.1002/mus.10457/full 
Walton, C., Kalmar, J. M., & Cafarelli, E. (2002). Effect of caffeine on self-sustained firing 
in human motor units. Journal of Physiology, 545(2), 671–679. 
https://doi.org/10.1113/jphysiol.2002.025064 
Wiles, J. D., Coleman, D., Tegerdine, M., & Swaine, I. L. (2006). The effects of caffeine 
ingestion on performance time, speed and power during a laboratory-based 1 km 
cycling time-trial. Journal of Sports Sciences, 24(11), 1165–1171. 
https://doi.org/10.1080/02640410500457687 
Zehr, E. P. (2002). Considerations for use of the Hoffmann reflex in exercise studies. 
European Journal of Applied Physiology, 86(6), 455–468. 
Effects of caffeine on neuromuscular function   39 
This article is protected by copyright. All rights reserved. 
https://doi.org/10.1007/s00421-002-0577-5 
Ziemann, U., Lönnecker, S., Steinhoff, B. J., & Paulus, W. (1996). Effects of antiepileptic 
drugs on motor cortex excitability in humans: A transcranial magnetic stimulation 






Figure 1. Experimental protocol. Pre and postcapsule measurements were identical and 
included H and M-wave recruitment curves followed by transcranial magnetic 
stimulation (TMS). During TMS, unconditioned motor evoked potentials (MEP), short-
interval intracortical inhibition (SICI), intracortical facilitation (ICF) and the duration of 
the TMS-evoked silent period (SP) were assessed. Baseline measures also included 
evaluation of squat and drop jump height and maximal voluntary contractions (MVCs). 
Electrical stimulation was applied immediately before the MVCs to assess Mmax, and 
during and after the MVCs (interpolated twitch technique, ITT) to assess voluntary 
activation and contractile properties. A capsule was ingested at the end of the 
precapsule measurement and the postcapsule test was conducted 1 h later. The fatigue 
protocol took place after the postcapsule test. During the inter-series periods, 
neuromuscular testing was carried out, as well as at task failure and during the recovery 
period. Blood samples were collected immediately after the precapsule measurements, 
before the postcapsule test, after the fatigue protocol and exactly 6 h after ingestion (~3 
h after the end of the fatigue protocol). 
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Figure 2. Pre- to postcapsule changes. A. Drop jump height. B. TMS-evoked silent period 
duration. Values are means (SD).  Significant difference between time-points: * for p < 
0.05. ♦ Significant difference between the post capsule measurement of the caffeine 
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Figure 3. Percentage of change from placebo, regarding the number of sets completed 
for each participant. Each bar represents a different participant and positive values 
indicate a longer endurance time with caffeine. A k-means clustering approach was 
used, revealing that the lowest within cluster sum of squares was observed for k = 3, 
with a cluster of participants who did not benefit from caffeine ingestion (n = 8, range: -
29.4 to 2.4% of change from placebo to caffeine), a cluster of participants with a 
considerable improvement on the caffeine day (n = 9, range: 11.20 to 74.29% change 
from placebo to caffeine), and a cluster with only one participant with a considerably 
higher level of responsiveness (141.5% change from placebo to caffeine), who was 
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Figure 4 A. Correlation between pre- to postcapsule changes in short-interval 
intracortical inhibition (SICI) and number of sets completed during the fatigue protocol 
in both trials. B. Correlation between pre- to postcapsule changes in the duration of the 
corticospinal silent period (SP) and number of sets completed during the fatigue 
protocol in both trials. SICI percentage change is related to the amplitude of the evoked 
test MEP. Thus high positive percentages reveal a decrease in SICI. The lines in the 
graphs are fit to the caffeine data points only, as there was no significant correlation 
between the variables in the placebo condition. NS: non-significant. 
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Figure 5. Changes in maximal voluntary contraction (MVC), voluntary activation (VA) 
and potentiated twitch (PTw) during fatigue and recovery. MVC, VA and PTw are 
expressed as a percentage of the postcapsule value in both trials. Values are means (SD). 
Significant difference from the postcapsule value for the pooled placebo and caffeine 
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Figure 6. Changes in maximal compound muscle action potential (Mmax) during fatigue 
and recovery. Mmax is expressed as a percentage of the postcapsule value in both trials. 
Values are means (SD). Significant difference from the postcapsule value: * for p < 0.05. 
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Figure 7. Changes in rate of perceived exertion (RPE) during the first sets of fatigue. ANOVA 
revealed a significant main effect of time and a significant main effect of drug. Post-hoc 
analysis showed a reduced RPE in the caffeine condition. Values are means (SD). Mixed 
ANOVA showed that this significant main effect of drug was present in those with observed 
improvements in the number of sets (above 10%) on the caffeine day (p = 0.006), but not in 







Table 1. Changes in neuromuscular variables during fatigue and recovery. Values are 
means ± SD. Significant difference from the postcapsule value: * for p < 0.05. When * is 
placed above the number, the difference was observed for the pooled placebo and 
caffeine data. Significant difference between conditions: ♦ for p < 0.05. MEP: motor 
evoked potential; Mmax: maximal compound muscle action potential; MVC: maximal 
voluntary contraction; RFD: rate of force development; SP: transcranial magnetic 
evoked silent period; VA: voluntary activation; PTw: potentiated twitch. 
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40% 60% Task failure 5 10 15
MVC (N) * * * * * *
   Placebo 1962.4 ± 374.4 1744.1 ± 460.6 1714.3 ± 397.4 1581.2 ± 339.8 1509.0 ± 483.2 1515.8 ± 417.2 1522.5 ± 437.6
   Caffeine 1898.3 ± 401.6 1633.8 ± 388.2 1578.0 ± 355.9 1456.3 ± 424.7 1395.5 ± 394.7 1405.1 ± 421.6 1471.2 ± 368.4
RFD 0-100 (N·s-1) * * * * * *
   Placebo 5613.5 ± 1446.3 4939.6 ± 2182.6 4296.4 ± 1652.3 3749.7 ± 2109.4 3444.2 ± 1797.9 3500.9 ± 1516.1 3855.2 ± 1886.5
   Caffeine 5129.7 ± 2185.9 4185.4 ± 1997.9 3971.4 ± 1942.9 3156.3 ± 2063.3 3113.1 ± 1586.4 3660.8 ± 2169.2 3503.6 ± 1953.0
RFD 0-200 (N·s
-1
) * * * * *
   Placebo 5208.4 ± 1403.2 4727.9 ± 1484.0 4134.0 ± 1276.1 3932.0 ± 1652.2 3463.5 ± 1475.1 3863.4 ± 1179.0 3906.8 ± 1757.2
   Caffeine 4875.9 ± 2059.8 4005.5 ± 1717.9 3923.8 ± 1161.0 3218.7 ± 1616.7 3383.7 ± 1311.1 3443.5 ± 1614.6 3466.9 ± 1620.8
RFD MAX (N·s-1) * * * * * *
   Placebo 11190.4 ± 2986.0 9109.1 ± 3085.1 8217.1 ± 2817.9 8239.7 ± 2496.0 6672.3 ± 2612.1 6674.3 ± 2109.1 7223.6 ± 2640.2
   Caffeine 9911.2 ± 4490.4 7783.3 ± 2942.5 8124.7 ± 3024.4 7436.2 ± 2978.3 6481.3 ± 2837.1 6503.8 ± 2219.4 6886.5 ± 1859.2
VA (%) * * * * * *
   Placebo 97.9 ± 2.3 96.0 ± 6.8 92.9 ± 12.3 90.5 ± 11.3 86.4 ± 13.0 91.5 ± 11.5 93.9 ± 7.0
   Caffeine 99.1 ± 0.9 95.0 ± 6.4 95.7 ± 4.9 86.7 ± 15.3 83.4 ± 20.9 94.3 ± 16.0 91.7 ± 16.2
PTw (N) * * * *
   Placebo 195.5 ± 55.1 188.2 ± 46.2 188.0 ± 47.4 169.3 ± 45.8 172.0 ± 48.0 164.1 ± 37.3 159.5 ± 36.7
   Caffeine 199.2 ± 44.8 196.1 ± 50.1 183.2 ± 40.2 180.3 ± 38.1 168.3 ± 48.6 173.2 ± 55.1 169.6 ± 47.6
Mmax (mA)
OVERALL * * * * * *
   Placebo 4.05 ± 1.51 3.34 ± 1.33 3.32 ± 1.47 3.50 ± 1.38 3.50 ± 1.37 3.50 ± 1.26 3.57 ± 1.49
   Caffeine 4.46 ± 1.67 3.38 ± 1.40 3.25 ± 1.33 3.59 ± 1.42 3.74 ± 1.73 3.60 ± 1.80 3.86 ± 1.68
Mmax (mA)
CLUSTER (CAFFEINE: +)
   Placebo 4.18 ± 1.51 3.57 ± 1.03* 3.47 ± 1.15 3.51 ± 1.12 3.37 ± 0.97 3.37 ± 0.95 3.38 ± 0.99
   Caffeine 4.60 ± 1.53 3.23 ± 0.66* 3.29 ± 0.82* 3.61 ± 1.16* 4.25 ± 1.24⬩ 4.20 ± 1.29⬩ 4.40 ± 1.34⬩
Mmax (mA)
CLUSTER (CAFFEINE: =/-)
   Placebo 3.95 ± 1.61 3.14 ± 1.59* 3.18 ± 1.78* 3.50 ± 1.65 3.62 ± 1.71 3.61 ± 1.53 3.74 ± 1.87
   Caffeine 4.34 ± 1.88 3.51 ± 1.87* 3.22 ± 1.72* 3.56 ± 1.70* 3.30 ± 2.04* 3.07 ± 2.09* 3.39 ± 1.89*
MEP (%)
   Placebo 11.5 ± 5.2 14.2 ± 6.6 16.0 ± 7.0 13.9 ± 5.3 14.4 ± 6.2 13.0 ± 5.2 14.6 ± 5.8
   Caffeine 11.7 ± 5.4 13.5 ± 6.5 14.6 ± 7.8 13.3 ± 6.7 14.1 ± 6.1 15.8 ± 9.6 15.6 ± 8.8
SP (ms) * * * *
   Placebo 73 ± 16 61 ± 18 59 ± 13 62 ± 13 63 ± 13 62 ± 15 64 ± 13
   Caffeine 68 ± 12 63 ± 11 61 ± 11 62 ± 13 62 ± 15 62 ± 15 64 ± 16
H-reflex (%)
   Placebo 44.2 ± 13.3 - - 40.3 ± 18.9 40.3 ± 16.6 43.5 ± 14.6 43.2 ± 15.8
   Caffeine 41.9 ± 17.6 - - 40.3 ± 17.7 42.7 ± 15.1 46.1 ± 14.3 43.4 ± 22.7
Fatigue Protocol Recovery (min)
Pre-fatigue
